...
首页> 外文期刊>Laboratory investigation >A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue
【24h】

A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue

机译:用于福尔马林固定石蜡包埋组织的神经胶质瘤标本的MGMT启动子高甲基化分析的简化实验室验证分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Glioma, and in particular high-grade astrocytoma termed glioblastoma multiforme (GBM), is the most common primary tumor of the brain. Epigenetic silencing of the MGMT (O6-methylguanine-DNA Methyl transferase) DNA repair gene by promoter methylation compromises DNA repair and has been associated with longer survival in patients with GBM who receive alkylating agents. The methylation status of the MGMT promoter is determined by methylation-specific polymerase chain reaction analysis (MSP). This protocol is often challenging with GBM specimens, because of extensive necrosis and scarcity of malignant cells. The objective of this study was to develop a reliable, clinically validated assay for detection of epigenetic silencing of the MGMT gene using formalin-fixed, paraffin-embedded brain tumor resections and methylation-specific PCR.
机译:胶质瘤,尤其是被称为多形性胶质母细胞瘤(GBM)的高级星形细胞瘤,是最常见的脑部原发肿瘤。通过启动子甲基化对MGMT(O6-甲基鸟嘌呤-DNA甲基转移酶)DNA修复基因进行表观遗传沉默会损害DNA修复,并且与接受烷化剂的GBM患者的生存期较长有关。 MGMT启动子的甲基化状态通过甲基化特异性聚合酶链反应分析(MSP)确定。对于GBM标本,由于广泛的坏死和恶性细胞稀缺,该协议通常具有挑战性。这项研究的目的是使用福尔马林固定,石蜡包埋的脑肿瘤切除术和甲基化特异性PCR技术,开发一种可靠的,经过临床验证的检测MGMT基因的表观遗传沉默的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号